Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: A report from the acute leukemia working party of the european group for blood and marrow transplantation

Haematologica

Volumn 96, Issue 9, 2011, Pages 1391-1394

  Chevallier, Patrice ^a   Labopin, Myriam ^b   Cornelissen, Jan ^c   Socié, Gérard ^d   Rocha, Vanderson ^b   Mohty, Mohamad ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAUSE OF DEATH; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GRANULOCYTIC SARCOMA; HIGH RISK PATIENT; HUMAN; LETTER; LEUKEMIC MYELOID SARCOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MYELOABLATIVE CONDITIONING; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SARCOMA, MYELOID; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 80052381153     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.041418     Document Type: Letter

References (10)

1. Campidelli C, Agostinelli C, Stitson R, Pileri SA. Extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009;132 (3):426-37.
2. Döhner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-74.
3. Tsimberidou AM, Kantarjian HM, Wen S, Keating MJ, O'Brien S, Brandt M, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukmia. Cancer. 2008;113(6):1370-8.
4. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol. 1995;13(7):1800-16.
5. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739-46.
6. Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17(6):1100-3.
7. Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340-50.
8. Chevallier P, Mohty M, Lioure B, Michel G, Contentin N, Deconinck E, et al. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGMTC. J Clin Oncol. 2008;26(30):4940-3.
9. Falini B, Lenze D, Hasserjian R, Coupland S, Jaehne D, Soupir C, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21(7):1566-70.
10. Choschzick M, Bacher U, Ayuk F, Lebeau A. Immuno-histochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation. J Clin Pathol. 2010;63(6):558-61